Cytori Cell Research Institute, Inc. Stock price

Equities

3750

JP3426500009

Real Estate Services

Market Closed - Japan Exchange 02:00:00 2024-03-29 am EDT 5-day change 1st Jan Change
968 JPY -2.22% Intraday chart for Cytori Cell Research Institute, Inc. -9.36% -15.01%
Sales 2022 1.34B 8.83M Sales 2023 2.14B 14.18M Capitalization 10.12B 66.89M
Net income 2022 -77M -509K Net income 2023 -1.06B -7M EV / Sales 2022 14.1 x
Net Debt 2022 8.42B 55.65M Net Debt 2023 7.38B 48.82M EV / Sales 2023 8.16 x
P/E ratio 2022
-133 x
P/E ratio 2023
-9.55 x
Employees 64
Yield 2022 *
-
Yield 2023
-
Free-Float 33.16%
More Fundamentals * Assessed data
Dynamic Chart
Samty Hotel Management K.K. agreed to acquire Hotel Kanazawa Co., Ltd. from Cytori Cell Research Institute, Inc.. CI
Cytori Cell Research Institute,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sakurajyuji Co., Ltd. signed an agreement to acquire approximately 1.60% stake in FRACTALE Corporation (TSE : 3750) from Aqua Strategic Investment Business Limited Partnership, managed by ACA Inc. for approximately ¥200 million. CI
FRACTALE Corporation canceled the acquisition of Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd. CI
FRACTALE Corporation announced that it has received ¥12.675 million in funding from Japan International Partners LLC CI
FRACTALE Corporation announced that it expects to receive ¥12.675 million in funding from Japan International Partners LLC CI
FRACTALE Corporation acquired 91% stake in Alegrox Hotel Management Co., Ltd from Shinji Ezure and others for ¥21.2 million. CI
FRACTALE Corporation agreed to acquire the remaining 43.63% stake in Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd. for ¥2.1 billion. CI
Osaka Mokuzai Sougo Ichiba Co., Ltd. cancelled the acquisition of Ikeda Fudosan Co., Ltd. from FRACTALE Corporation. CI
Seijiro Shirahama and FRACTALE Corporation completed the acquisition of Cytori Therapeutics K.K. and Cell Therapy Assets in Japan. CI
Seijiro Shirahama entered into an asset and equity purchase agreement to acquire Cytori Therapeutics K.K. and Cell Therapy Assets in Japan for $3 million. CI
An individual cancelled the acquisition of International Luxury Media Co., Ltd. from Seven Seas Holdings Co.,Ltd.. CI
Osaka Mokuzai Sougo Ichiba Co., Ltd. signed a contract to acquire Ikeda Fudosan Co., Ltd. from FRACTALE Corporation for ¥1.7 billion. CI
Seven Seas Holdings Co.,Ltd. cancelled the acquisition of Nuts Real Estate LLC from Nuts Real Estate Institute. CI
An individual agreed to acquire International Luxury Media Co., Ltd. from Seven Seas Holdings Co.,Ltd. for ¥10 million. CI
More news
1 day-2.22%
1 week-9.36%
Current month-10.62%
1 month-10.62%
3 months-15.01%
6 months-17.55%
Current year-15.01%
More quotes
1 week
881.00
Extreme 881
1 069.00
1 month
881.00
Extreme 881
1 138.00
Current year
881.00
Extreme 881
1 168.00
1 year
730.00
Extreme 730
1 320.00
3 years
730.00
Extreme 730
1 750.00
5 years
408.00
Extreme 408
1 841.00
10 years
160.00
Extreme 160
1 841.00
More quotes
Managers TitleAgeSince
Chairman 66 18-06-19
President 51 17-11-30
Director/Board Member 53 00-08-31
Members of the board TitleAgeSince
Director/Board Member 53 00-08-31
President 51 17-11-30
Director/Board Member 47 13-05-31
More insiders
Date Price Change Volume
24-03-29 968 -2.22% 38 700
24-03-28 990 -4.53% 135,600
24-03-27 1,037 -0.19% 40,300
24-03-26 1,039 -2.07% 33,000
24-03-25 1,061 -0.66% 26,300

Delayed Quote Japan Exchange, March 29, 2024 at 02:00 am EDT

More quotes
Cytori Cell Research Institute Inc is a Japan-based company mainly engaged in the real asset business. The Company operates through two segments. The Real Asset segment is engaged in the purchase and sales of real estate and investment of real estate business related projects, as well as development, renovation and opening of hotels, and operation of hotels. The Medical segment is engaged in the investment of regenerative medicine business centered on cell therapy services, as well as sales of medical equipment and consumables. The main products include Celusion centrifuge and the Celusion cell therapy kit.
More about the company
  1. Stock
  2. Equities
  3. Stock Cytori Cell Research Institute, Inc. - Japan Exchange